Immunomodulatory Activities of the Benzoxathiole Derivative BOT-4-One Ameliorate Pathogenic Skin Inflammation in Mice
Authors:
- 1 January 2016
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (1) , 107-116
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergensJournal of Allergy and Clinical Immunology, 2014
- T cell receptor signalling networks: branched, diversified and boundedNature Reviews Immunology, 2013
- Modification of Cysteine 179 of IκBα Kinase by Nimbolide Leads to Down-regulation of NF-κB-regulated Cell Survival and Proliferative Proteins and Sensitization of Tumor Cells to Chemotherapeutic AgentsJournal of Biological Chemistry, 2010
- IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cellsProceedings of the National Academy of Sciences, 2009
- Atopic DermatitisNew England Journal of Medicine, 2008
- Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune DiseaseClinical Microbiology Reviews, 2006
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- T-Cell-Mediated AutoimmunityThe American Journal of Pathology, 2003
- The Immunomodulatory Role of CD4-Positive Cytotoxic T-lymphocytes in Health and DiseaseInternational Reviews of Immunology, 1999
- Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopyAllergy, 1992